Status:
COMPLETED
Global Coagulation Assessment in Cirrhosis and ACLF
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Acute-On-Chronic Liver Failure
Cirrhosis, Liver
Eligibility:
All Genders
18-65 years
Brief Summary
Background: Patients with cirrhosis and acute-on-chronic liver failure (ACLF) may have bleeding complications which can lead to increased mortality. Standard coagulation tests (SCTs) like prothrombin ...
Eligibility Criteria
Inclusion
- All patients with Acute on Chronic Liver Failure
- All patients with cirrhosis of Liver
Exclusion
- Recent blood or blood component transfusion in last 2 weeks
- HIV infection
- Antiplatelet, anticoagulant or antifibrinolytic therapy
- Patients on Dialysis
- Pregnant females
- Active malignancy in last 5 years
- Chronic heart failure
- Chronic pulmonary disease
- End stage renal disease
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04332484
Start Date
January 1 2018
End Date
August 31 2019
Last Update
April 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PGIMER
Chandigarh, India, 160012